4LGK | date | ![]() |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | AU, CL | enzyme |
| ||||||||||||
Gene Ontology ![]() |
| ||||||||||||||
Primary reference | The mode of action of anticancer gold-based drugs: a structural perspective., Messori L, Scaletti F, Massai L, Cinellu MA, Gabbiani C, Vergara A, Merlino A, Chem Commun (Camb). 2013 Sep 18. PMID:24045294 |
Data retrieval |
![]() |
View 4LGK in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |